Sponsor Pipeline

Rhythm Pharmaceuticals, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
2
Recruiting
2
Phase 3
1
Disease Areas
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-07 NCT05093634
EMANATE: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R…		 Trial completed
2026-08-07 NCT05093634
EMANATE: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R…		 date change Completion moved earlier: 2026-12-31 -> 2026-06-30
Active Trials by Phase
Phase 3
2
Phase 2
2
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06760546 A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of… Hypothalamic Obesity Recruiting
NCT05774756 A Trial of Setmelanotide in Acquired Hypothalamic Obesity Hypothalamic Obesity Active, Not Recruiting
Phase 2
NCT07156578 A Long-Term Study of Bivamelagon in Participants With Hypothalamic Obesity (HO) Hypothalamic Obesity Enrolling by Invitation
NCT06772597 A Study of Setmelanotide in Patients With Prader-Willi Syndrome Prader-Willi Syndrome Active, Not Recruiting
Phase 1/2
NCT06239116 A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment Hypothalamic Obesity Recruiting
Disease Areas
Obesity (5)
Get alerts when Rhythm Pharmaceuticals, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free